Skip to main content
. 2022 Jan 21;12(1):421–436. doi: 10.3233/JPD-212892

Fig. 1.

Fig. 1

A) Sex-related change in MDS-UPDRS part III ON; B) Sex-related change in MDS-UPDRS part II; C) Sex-related change in LED; D) Sex-related estimated probability of initiation of symptomatic therapy. LED, levodopa equivalent dose; MDS-UPDRS, the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale.